Chemogenetics Modulation of Electroacupuncture Analgesia in Mice Spared Nerve Injury-Induced Neuropathic Pain through TRPV1 Signaling Pathway

I-Han Hsiao,Chia-Ming Yen,Hsin-Cheng Hsu,Hsien-Yin Liao,Yi-Wen Lin

DOI: https://doi.org/10.3390/ijms25031771

IF: 5.6

2024-02-02

International Journal of Molecular Sciences

Abstract:Neuropathic pain, which is initiated by a malfunction of the somatosensory cortex system, elicits inflammation and simultaneously activates glial cells that initiate neuroinflammation. Electroacupuncture (EA) has been shown to have therapeutic effects for neuropathic pain, although with uncertain mechanisms. We suggest that EA can reliably cure neuropathic disease through anti-inflammation and transient receptor potential V1 (TRPV1) signaling pathways from the peripheral to the central nervous system. To explore this, we used EA to treat the mice spared nerve injury (SNI) model and explore the underlying molecular mechanisms through novel chemogenetics techniques. Both mechanical and thermal pain were found in SNI mice at four weeks (mechanical: 3.23 ± 0.29 g; thermal: 4.9 ± 0.14 s). Mechanical hyperalgesia was partially attenuated by 2 Hz EA (mechanical: 4.05 ± 0.19 g), and thermal hyperalgesia was fully reduced (thermal: 6.22 ± 0.26 s) but not with sham EA (mechanical: 3.13 ± 0.23 g; thermal: 4.58 ± 0.37 s), suggesting EA's specificity. In addition, animals with Trpv1 deletion showed partial mechanical hyperalgesia and no significant induction of thermal hyperalgesia in neuropathic pain mice (mechanical: 4.43 ± 0.26 g; thermal: 6.24 ± 0.09 s). Moreover, we found increased levels of inflammatory factors such as interleukin-1 beta (IL1-β), IL-3, IL-6, IL-12, IL-17, tumor necrosis factor alpha, and interferon gamma after SNI modeling, which decreased in the EA and Trpv1−/− groups rather than the sham group. Western blot and immunofluorescence analysis showed similar tendencies in the dorsal root ganglion, spinal cord dorsal horn, somatosensory cortex (SSC), and anterior cingulate cortex (ACC). In addition, a novel chemogenetics method was used to precisely inhibit SSC to ACC activity, which showed an analgesic effect through the TRPV1 pathway. In summary, our findings indicate a novel mechanism underlying neuropathic pain as a beneficial target for neuropathic pain.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

### The Problem the Paper Attempts to Solve

This paper aims to explore the mechanism by which electroacupuncture (EA) alleviates neuropathic pain through the inhibition of inflammatory responses and the transient receptor potential vanilloid 1 (TRPV1) signaling pathway. Specifically, the study simulates neuropathic pain by constructing a mouse spinal nerve injury (SNI) model and evaluates the effectiveness of electroacupuncture treatment.

#### Main Issues:
1. **Can electroacupuncture effectively alleviate neuropathic pain?**
- The study evaluates the efficacy of electroacupuncture in the SNI mouse model through behavioral tests (mechanical allodynia and thermal hyperalgesia).

2. **How does electroacupuncture exert analgesic effects through anti-inflammatory actions and the TRPV1 signaling pathway?**
- The study examines the impact of electroacupuncture on the levels of various inflammatory factors (such as IL-1β, IL-6, TNF-α, etc.) in the serum of SNI mice.

3. **What is the role of the TRPV1 signaling pathway in neuropathic pain and its regulatory mechanisms?**
- The study investigates the expression changes of TRPV1 and related molecules in different brain regions (such as the dorsal root ganglion, dorsal horn of the spinal cord, somatosensory cortex, and anterior cingulate cortex) using techniques like gene knockout (Trpv1−/−) and immunofluorescence staining.

#### Conclusion:
The study results indicate that electroacupuncture can significantly alleviate neuropathic pain in the SNI mouse model, and this effect is closely related to the inhibition of inflammatory responses and the downregulation of the TRPV1 signaling pathway. Additionally, chemogenetic techniques further validate the important role of the pathway from the somatosensory cortex to the anterior cingulate cortex in pain regulation. These findings provide new mechanisms and potential therapeutic targets for the treatment of neuropathic pain.